A justified suspicion of non-compliance with quality requirements concerned the loss on drying parameter for batch DQ2011, which could indicate deviations in capsule quality, but subsequent analyses showed compliance with the extended specification. Potential effects: no significant health effects for patients.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
The product may be used according to the package leaflet; in case of any doubts, patients should consult a doctor or pharmacist.
The Chief Pharmaceutical Inspectorate declared the expiry of decision No. 6/WS/2024 suspending the distribution of Ibuprofen Dr. Max 400 mg soft capsules nationwide, recognizing that all batches do no...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related